CPIX - Cumberland Pharmaceuticals Inc. (CPIX) Q4 2023 Earnings Call Transcript
2024-03-05 22:06:02 ET
Cumberland Pharmaceuticals Inc. (CPIX)
Q4 2023 Earnings Conference Call
March 05 2024 04:30 PM ET
Company Participants
Molly Aggas - Account Supervisor, Dalton Agency
A. J. Kazimi - Chairman and Chief Executive Officer
Todd Anthony - Vice President, Organizational Development
John Hamm - Chief Financial Officer
Conference Call Participants
Presentation
Operator
Good afternoon, and welcome to Cumberland Pharmaceuticals 2023 Financial Report and Company Update. This call is being recorded at Cumberland's request and will be archived on the company's website for one year from today's date.
I would now like to turn it over to Molly Aggas, Account Supervisor at the Dalton Agency, who handles Cumberland's communications. Molly, please go ahead.
Molly Aggas
Hello, everyone. Good afternoon. Thanks for joining us today. This afternoon, Cumberland issued a press release announcing the company's annual financial results with an operational update for the year ending December 31, 2023. The release, which includes the related financial tables can be found on the company's website at www.cumberlandpharma.com.
Management will share an overview of those financial results during today's call. They'll also provide an overall company update, including a discussion of Cumberland's brand, pipeline and partners. Participating in today's call are A. J. Kazimi, Cumberland's Chief Executive Officer; Todd Anthony, Vice President, Organizational Development; and John Hamm, Chief Financial Officer.
Please keep in mind that their discussions may include forward-looking statements as defined in the Private Securities Reform Act. Those statements reflect the company's current views and expectations concerning future events, and may involve risks and uncertainties....
Cumberland Pharmaceuticals Inc. (CPIX) Q4 2023 Earnings Call Transcript